Microbiome Global Market Report 2026

The microbiome refers to a community of microbes, including fungi, bacteria, and viruses, that inhabit a specific environment. It encompasses all the genetic material of bacteria, fungi, protozoa, and viruses residing on and within the human body. The bacteria within the microbiome also support digestion, regulate the immune system, protect against disease-causing microbes, and produce essential vitamins such as Vitamin K, which is necessary for blood clotting, and B vitamins including B12, thiamine, and riboflavin.

The main types of microbiomes include bacteria, archaea, viruses, and other microbial communities. Bacteria are single-celled microorganisms classified under the domain Bacteria, and they are among the most diverse and abundant forms of life on Earth, thriving in a variety of environments. Microbiome-related products include therapeutics and diagnostics, and the associated technologies involve genomics, proteomics, and metabolomics. These are applied in conditions such as inflammatory bowel disease, gastrointestinal disorders, metabolic disorders, cancers, and other diseases.

Tariffs have impacted the microbiome market by increasing the cost of importing sequencing equipment, laboratory reagents, and advanced therapeutics. This has affected key segments like genomics-based diagnostics and therapeutics, particularly in North America and Europe, where reliance on imported biotech tools is high. The higher costs may slow R&D initiatives and commercialization, but it also encourages local manufacturing and innovation, potentially reducing dependency on foreign imports and strengthening domestic supply chains.

The microbiome market research report is one of a series of new reports from The Business Research Company that provides microbiome market statistics, including microbiome industry global market size, regional shares, competitors with a microbiome market share, detailed microbiome market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome industry. This microbiome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microbiome market size has grown rapidly in recent years. It will grow from $0.82 billion in 2025 to $0.94 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising awareness about gut health, increased research funding in microbiome studies, growth in probiotic consumption, advances in sequencing technologies, partnerships between research institutions and biotech firms.

The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.64 billion in 2030 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to integration of ai in microbiome analysis, personalized medicine adoption, expansion of microbiome-based therapeutics, rise in chronic disease prevalence, increasing demand for functional foods and supplements. Major trends in the forecast period include personalized microbiome-based therapies, probiotic and prebiotic innovation, microbiome diagnostic development, gut-brain axis research expansion, microbiome data integration and analysis.

Rising healthcare expenditure is expected to drive growth in the microbiome market in the coming years. Healthcare expenditure refers to the total financial resources spent on healthcare services, related goods, and activities within a specific healthcare system or economy over a defined period. Such spending plays a critical role in supporting the microbiome market, as increased investments in research and development, along with growing awareness of the microbiome's importance to human health, are driving demand for microbiome-based therapies and products. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per person. Therefore, increasing healthcare spending is contributing to the expansion of the microbiome market.

Leading companies in the microbiome market are focusing on innovations such as personalized health insights, which aim to empower individuals by providing tailored reports highlighting specific health concerns. Personalized health insights involve customized, data-driven information and recommendations based on an individual's unique health profile. For instance, in September 2024, Redcliffe Labs, an India-based medical and diagnostic laboratory company, launched Gut Microbiome and HealthEx tests to enhance preventive healthcare. The gut microbiome test analyzes gut health to provide insights into immune function, metabolism, and mental well-being, while the advanced blood test evaluates DNA to assess potential health risks linked to lifestyle, diet, and genetics. Both tests offer personalized recommendations to help individuals better manage their health.

In December 2023, L'Oreal S.A., a France-based cosmetics company, acquired Lactobio for an undisclosed amount. This acquisition enables L'Oreal to strengthen its expertise in microbiome science and enhance its product offerings by incorporating innovative solutions based on probiotics. Lactobio is a Denmark-based biotechnology research company leveraging microbiome science to develop novel health interventions.

Major companies operating in the microbiome market are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix Inc, Locus Biosciences, Osel Inc., Xbiome Co. Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, BugSpeaks, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome

North America was the largest region in the microbiome market in 2025. The regions covered in the microbiome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the microbiome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microbiome market consists of sales of firmicutes, bacteroidetes, and actinobacteria. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microbiome Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses microbiome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microbiome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbiome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Microbe Category: Bacteria; Archaea; Viruses; Other Microbiomes
• 2) By Product: Therapeutics; Diagnostics
• 3) By Technology: Genomics; Proteomics; Metabolomics
• 4) By End-Use: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
• Subsegments:
• 1) By Bacteria: Probiotic Bacteria; Pathogenic Bacteria; Environmental Bacteria; Bacterial Communities In Various Ecosystems
• 2) By Archaea: Methanogens; Halophiles; Acidophiles; Other Extremophiles
• 3) By Viruses: Bacteriophages; Eukaryotic Viruses; Environmental Viruses
• 4) By Other Microbiomes: Fungi; Protists; Helminths; Mycobiome
• Companies Mentioned: Seres Therapeutics; Enterome Bioscience; Ferring Pharmaceuticals; Vedanta BioSciences; Second Genome Inc.; Microbiotica; Rebiotix Inc; Locus Biosciences; Osel Inc.; Xbiome Co. Ltd; Microba Life Sciences; Biome Australia; Shoreline Biome; BugSpeaks; Atlas Biomed; BiomX Ltd; ImmuneBiotech Medical Sweden AB; MetaboGen AB; Viome; PharmaBiome; NCCR Microbiomes; MaaT Pharma; Eligo Bioscience; T3 Pharmaceuticals; MicroBiome Therapeutics LLC; OpenBiome; Microbiome Insights Inc.; Lallemand Health Solutions; Mybiotics Pharma; DayTwo; Next Biosciences; ViThera Pharmaceuticals Inc.; Inqaba Biotechnical Industries (Pty); SNIPR Biome; MyBiome
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.